Trans-lesion DNA synthesis (TLS) is a DNA damage-tolerance mechanism that uses low-fidelity DNA polymerases to replicate damaged DNA. The inherited cancer-propensity syndrome xeroderma pigmentosum variant (XPV) results from error-prone TLS of UV-damaged DNA. TLS is initiated when the Rad6/Rad18 complex monoubiquitinates proliferating cell nuclear antigen (PCNA), but the basis for recruitment of Rad18 to PCNA is not completely understood. Here, we show that Rad18 is targeted to PCNA by DNA polymerase eta (Polη), the XPV gene product that is mutated in XPV patients. The C-terminal domain of Polη binds to both Rad18 and PCNA and promotes PCNA monoubiquitination, a function unique to Polη among Y-family TLS polymerases and dissociable from its ...
The variant form of the human syndrome xeroderma pigmentosum (XPV) is caused by a deficiency in DNA ...
The E3 ubiquitin ligase Rad18 mediates tolerance of replication fork-stalling bulky DNA lesions, but...
Fanconi anemia (FA) is a cancer susceptibility syndrome characterized by sensitivity to DNA-damaging...
Trans-lesion DNA synthesis (TLS) is a DNA damage-tolerance mechanism that uses low-fidelity DNA poly...
Replicative DNA polymerases are frequently stalled by DNA lesions. The resulting replication blockag...
The E3 ubiquitin ligase Rad18 guides DNA Polymerase eta (Polη) to sites of replication fork stalling...
Switching between replicative and translesion synthesis (TLS) DNA polymerases are crucial events for...
The association of Rad18 with Polη is crucial for efficient translesion synthesis and DNA damage tol...
The association of Rad18 with Polη is crucial for efficient translesion synthesis and DNA damage tol...
Translesion DNA synthesis (TLS) is a DNA damage tolerance mechanism in which specialized low-fidelit...
Translesion DNA synthesis (TLS) is a DNA damage tolerance mechanism in which specialized low-fidelit...
Translesion DNA synthesis (TLS) is a DNA damage tolerance mechanism in which specialized low-fidelit...
Translesion DNA synthesis (TLS) is a DNA damage tolerance mechanism in which specialized low-fidelit...
Switching between replicative and translesion synthesis (TLS) DNA polymerases are crucial events for...
DNA damage blocks the progression of the replication fork. In order to circumvent the damaged bases,...
The variant form of the human syndrome xeroderma pigmentosum (XPV) is caused by a deficiency in DNA ...
The E3 ubiquitin ligase Rad18 mediates tolerance of replication fork-stalling bulky DNA lesions, but...
Fanconi anemia (FA) is a cancer susceptibility syndrome characterized by sensitivity to DNA-damaging...
Trans-lesion DNA synthesis (TLS) is a DNA damage-tolerance mechanism that uses low-fidelity DNA poly...
Replicative DNA polymerases are frequently stalled by DNA lesions. The resulting replication blockag...
The E3 ubiquitin ligase Rad18 guides DNA Polymerase eta (Polη) to sites of replication fork stalling...
Switching between replicative and translesion synthesis (TLS) DNA polymerases are crucial events for...
The association of Rad18 with Polη is crucial for efficient translesion synthesis and DNA damage tol...
The association of Rad18 with Polη is crucial for efficient translesion synthesis and DNA damage tol...
Translesion DNA synthesis (TLS) is a DNA damage tolerance mechanism in which specialized low-fidelit...
Translesion DNA synthesis (TLS) is a DNA damage tolerance mechanism in which specialized low-fidelit...
Translesion DNA synthesis (TLS) is a DNA damage tolerance mechanism in which specialized low-fidelit...
Translesion DNA synthesis (TLS) is a DNA damage tolerance mechanism in which specialized low-fidelit...
Switching between replicative and translesion synthesis (TLS) DNA polymerases are crucial events for...
DNA damage blocks the progression of the replication fork. In order to circumvent the damaged bases,...
The variant form of the human syndrome xeroderma pigmentosum (XPV) is caused by a deficiency in DNA ...
The E3 ubiquitin ligase Rad18 mediates tolerance of replication fork-stalling bulky DNA lesions, but...
Fanconi anemia (FA) is a cancer susceptibility syndrome characterized by sensitivity to DNA-damaging...